Social Media & Drug Companies: Do They Mix?

Featured on the Wolters Kluwer Intelligent Solutions blog, our contributor Cathy Betz tackles the topic of pharmaceutical corporations on Facebook:

Facebook has told pharmaceutical companies that as of August 15, they can no longer disable the comment feature on their Facebook pages. Although pharmaceutical brand pages will no longer be able to disable commenting on their posts, Facebook will, on a case by case basis, allow disabling of the commenting function on branded pages solely dedicated to a prescription drug. But pages that are focused on the companies themselves or that serve as disease- or patient-specific communities will have to be open to public comment….for the full article click here